A source of hope for platinum-resistant ovarian cancer?

Lancet. 2021 Jan 23;397(10271):254-256. doi: 10.1016/S0140-6736(21)00128-8.

Authors

Sarah P Blagden¹, Shibani Nicum²

Affiliations

¹ Department of Oncology, University of Oxford, Oxford, OX3 7DG, UK. Electronic address: sarah.blagden@oncology.ox.ac.uk.
² Churchill Hospital, Oxford University NHS Foundation Trust, Oxford, UK.

PMID: 33485431
DOI: 10.1016/S0140-6736(21)00128-8

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Deoxycytidine / analogs & derivatives
Double-Blind Method
Female
Gemcitabine
Humans
Ovarian Neoplasms* / drug therapy
Platinum*
Pyrazoles
Pyrimidinones

Substances

Pyrazoles
Pyrimidinones
Deoxycytidine
Platinum
adavosertib
Gemcitabine